63 related articles for article (PubMed ID: 9548462)
1. Spectratyping of TCRs expressed by CTL-infiltrating minor histocompatibility antigen-disparate allografts.
Johnston SL; Borson ND; Wettstein PJ
J Immunol; 1997 Dec; 159(11):5233-45. PubMed ID: 9548462
[TBL] [Abstract][Full Text] [Related]
2. Spectratyping of TCR expressed by CTL-infiltrating male antigen (HY)-disparate allografts.
Johnston SL; Wettstein PJ
J Immunol; 1998 Apr; 160(7):3374-84. PubMed ID: 9531297
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor diversity in CTLs specific for the CTT-1 and CTT-2 minor histocompatibility antigens.
Johnston SL; Wettstein PJ
J Immunol; 1997 Sep; 159(6):2606-15. PubMed ID: 9300679
[TBL] [Abstract][Full Text] [Related]
4. Repertoires of T cell receptors expressed by graft-infiltrating T cells evolve during long-term recall responses to single minor histocompatibility antigens.
Wettstein PJ; Strausbauch M; Borson N
Int Immunol; 2007 Apr; 19(4):523-34. PubMed ID: 17369191
[TBL] [Abstract][Full Text] [Related]
5. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
6. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
7. Diversity of alpha and beta subunits of T-cell receptors specific for the H4 minor histocompatibility antigen.
Johnston SL; Graham D; Wettstein PJ
Immunogenetics; 1997; 46(1):17-28. PubMed ID: 9148784
[TBL] [Abstract][Full Text] [Related]
8. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
9. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
Jantzer P; Schendel DJ
Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
[TBL] [Abstract][Full Text] [Related]
10. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
Liu Y; Zhu P; Hu YM
Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
[TBL] [Abstract][Full Text] [Related]
11. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
12. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
[TBL] [Abstract][Full Text] [Related]
13. Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL.
Gundlach BR; Wiesmüller KH; Junt T; Kienle S; Jung G; Walden P
J Immunol; 1996 May; 156(10):3645-51. PubMed ID: 8621898
[TBL] [Abstract][Full Text] [Related]
14. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
15. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
[TBL] [Abstract][Full Text] [Related]
16. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
[TBL] [Abstract][Full Text] [Related]
17. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
Nevala WK; Paul C; Wettstein PJ
Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
[TBL] [Abstract][Full Text] [Related]
18. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
Zhu X; Zhu P; Guo XL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
[TBL] [Abstract][Full Text] [Related]
19. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.
Friedman TM; Gilbert M; Briggs C; Korngold R
J Immunol; 1998 Jul; 161(1):41-8. PubMed ID: 9647205
[TBL] [Abstract][Full Text] [Related]
20. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
